Epilepsy
📧 Sign up to get email alerts when something new happens for Epilepsy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-08-15Clinical Trial Update: Effect of Brivaracetam (BRV) on Nonpsychotic Behavioral Side Effects in Subjects Treated Previously With Levetiracetam (LEV) [Phase 3]
A Phase 3 trial evaluating whether Brivaracetam reduces nonpsychotic behavioral side effects in epilepsy patients previously treated with Le…
-
CLINICAL_TRIALS trial_result · 2016-08-15Clinical Trial Update: Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures [Phase 3]
Phase 3 trial update on brivaracetam for partial onset seizures reports efficacy and safety results.
-
CLINICAL_TRIALS trial_result · 2016-08-11Clinical Trial Update: Open-label, Randomized, Active-controlled Study of LEV Used as Monotherapy in Patients With Partial-Onset Seizures [Phase 3]
A Phase 3 open-label, randomized, active-controlled study evaluating levetiracetam as monotherapy for partial-onset seizures has completed; …
-
FDA approval · 2016-08-09FDA Approved: TIAGABINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for Tiagabine hydrochloride by Teva Pharmaceuticals USA, Inc. This action updates the product's …
-
CLINICAL_TRIALS trial_result · 2016-08-04Clinical Trial Update: Mobile Phone Radiation and Brain Rhythm in Epileptic Patients
A completed clinical trial evaluating whether mobile phone radiation affects brain rhythms in patients with epilepsy.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2016-08-03Clinical Trial Update: The Effect of Child Position on the Results of Hyperventilation During Routine Electroencephalography [NA]
Clinical trial update evaluating whether child position influences EEG results during hyperventilation in routine electroencephalography for…
-
FDA approval · 2016-08-01FDA Approved: LEVETIRACETAM SOLUTION — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for LEVETIRACETAM SOLUTION (levetiracetam) from Chartwell RX, LLC, approving a new solution formulat…
-
CLINICAL_TRIALS trial_result · 2016-07-29Clinical Trial Update: A Safety and Feasibility Study of Enteral LVT vs. Standard of Care for Seizure Control in Pediatric CM [Phase 2]
A Phase 2 safety and feasibility trial assessed enteral Levetiracetam (LVT) versus standard of care for seizure control in pediatric cerebra…
-
CLINICAL_TRIALS research · 2016-07-26Clinical Trial Update: Epileptogenic Zone's Cartography by Quantification of EEG's Signal and Intracerebral Stimulation. [NA]
Updates to a clinical trial investigating cartography of the epileptogenic zone via EEG signal quantification and intracerebral stimulation.…
-
CLINICAL_TRIALS trial_result · 2016-07-22Clinical Trial Update: A Study of Meditation as a Treatment for Epilepsy [NA]
This document reports a completed clinical trial investigating meditation as a treatment for epilepsy.
-
FDA approval · 2016-07-18FDA Approved: CLONAZEPAM — Supplemental Application (Solco Healthcare LLC)
The FDA approved a supplemental application for clonazepam submitted by Solco Healthcare LLC.
-
FDA approval · 2016-07-18FDA Approved: ZONISAMIDE — Supplemental Application (BluePoint Laboratories)
FDA approved a supplemental application for Zonisamide from BluePoint Laboratories.
-
FDA approval · 2016-07-18FDA Approved: CLONAZEPAM — Supplemental Application (Advagen Pharma Ltd)
The FDA approved a supplemental application for clonazepam submitted by Advagen Pharma Ltd.
-
FDA approval · 2016-07-18FDA Approved: ZONISAMIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approves a supplemental application for zonisamide submitted by Sun Pharmaceutical Industries, Inc.
-
FDA approval · 2016-06-24FDA Approved: DIAZEPAM — Original Application (Chartwell Governmental & Specialty RX, LLC.)
FDA approved the original application for diazepam oral from Chartwell Governmental & Specialty RX, LLC. This marks approval of a generic di…
-
FDA label_change · 2016-06-17FDA Approved: TEGRETOL — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for Tegretol (carbamazepine) to update the labeling language.
-
FDA approval · 2016-06-17FDA Approved: LAMOTRIGINE — Original Application (Dr. Reddys Laboratories Inc.)
The FDA approved the original application for a generic Lamotrigine product from Dr. Reddys Laboratories Inc.
-
FDA approval · 2016-06-16FDA Approved: DILANTIN-125 — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for DILANTIN-125 (phenytoin) submitted by Viatris Specialty LLC.
-
FDA approval · 2016-06-16FDA Approved: CEREBYX — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental application for Cerebyx (fosphenytoin sodium) submitted by Pfizer Laboratories Div Pfizer Inc, expanding the…
-
CLINICAL_TRIALS trial_result · 2016-06-14Clinical Trial Update: Analysis of Lateralization of Language in Epileptic Children by Near-infrared Spectroscopy (NIRS) [NA]
This clinical trial update analyzes language lateralization in epileptic children using near-infrared spectroscopy (NIRS). The study status …
-
FDA approval · 2016-06-13FDA Approved: KLONOPIN — Supplemental Application (H2-Pharma, LLC)
The FDA approved a supplemental application for Klonopin (clonazepam) from H2-Pharma, LLC. The action updates labeling as part of the supple…
-
CLINICAL_TRIALS trial_result · 2016-06-07Clinical Trial Update: A Study of the Structure and Function of the Retina in Adult Patients With Refractory Complex Partial Seizures Treated With Vigabatrin (Sabril®) [Phase 4]
Phase 4 trial updating retinal structure and function in adults with refractory complex partial seizures treated with vigabatrin (Sabril); r…
-
FDA approval · 2016-06-03FDA Approved: BRIVIACT — Supplemental Application (UCB, Inc.)
FDA approved a supplemental application for Briviact (brivaracetam) submitted by UCB, Inc.
-
FDA approval · 2016-06-03FDA Approved: BRIVIACT — Supplemental Application (UCB, Inc.)
FDA approved a supplemental application for Briviact (brivaracetam) submitted by UCB, Inc.
-
FDA approval · 2016-06-03FDA Approved: BRIVIACT — Supplemental Application (UCB, Inc.)
The FDA approved a supplemental application for Briviact (brivaracetam) submitted by UCB, Inc.